PRO114 EQ-5D UTILITY ESTIMATES FOR PATIENTS WITH SYSTEMIC...

PRO114 EQ-5D UTILITY ESTIMATES FOR PATIENTS WITH SYSTEMIC SCLEROSIS (SSC). INSIGHTS FROM THE FOCUSSCED PHASE III EFFICAY AND SAFETY STUDY OF TOCILIZUMAB.

Orfanos, P., Felizzi, F., Thuresson, P.O.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
22
Language:
english
Journal:
Value in Health
DOI:
10.1016/j.jval.2019.09.2444
Date:
November, 2019
File:
PDF, 324 KB
english, 2019
Conversion to is in progress
Conversion to is failed